Thank you!
Your support is sustaining the future of local news in our communities.

BD intensifies syringe output to meet U.S. demand amid China quality concerns

BD intensifies syringe output to meet U.S. demand amid China quality concerns

BD’s North Canaan plant has increased its output of syringes by more than 40% to meet the needs of U.S. healthcare customers after the FDA launched an ongoing investigation into quality issues with plastic syringes made in China.

Provided

NORTH CANAAN — Becton, Dickinson and Company (BD) has ramped up its production of syringes at its North Canaan plant in response to quality issues with plastic syringes imported from China which were uncovered late last year by the U.S. Food and Drug Administration (FDA).

BD, a leading global medical technology company and Northwest Connecticut’s largest employer, responded to the FDA’s recommendation that consumers, healthcare providers and healthcare facilities transition away from plastic syringes made in China by increasing its domestic manufacturing of syringes at the company’s Connecticut and Nebraska facilities.

Since January, BD’s 385,000-square-foot North Canaan plant has increased its output of syringes “by over 40% to meet the needs of U.S. healthcare customers,” according to Fallon McLoughlin, director of public relations and corporate communications for the Franklin Lakes, N.J.-based company.

“BD has achieved this increase by driving operational efficiencies and relocating some production lines from other BD plants,” said McLoughin.

“We’ve added over 100 full-time associates in the last year, and currently have more than 500 full-time associates and nearly 50 contingent associates,” she said of the North Canaan site, which began its operations in 1961 with eight employees at a 25,000-square-foot facility.

BD draws its employees from throughout Northwest Connecticut and neighboring New York.

McLaughlin noted that its Connecticut plant primarily manufactures small-size syringes, and syringe and needle combination products that are “critical to the delivery of healthcare.”

Operations take place around the clock, producing more than 2 billion medical devices each year that are sold in every region worldwide.

Responding to consumer needs

In March, Eric Borin, president of BD Medication Delivery Solutions, announced a statement saying: “BD has the capacity to support additional syringe demand and is further increasing U.S. production to help ensure continuity of patient care.”

Since the initial FDA safety communication in November 2023, he noted, “BD has increased domestic manufacturing of syringes in our Nebraska and Connecticut facilities to respond to customer needs. Ensuring the safety and quality of our products is the top priority at BD.”

Borin further noted at the time that “The latest FDA safety communication does not include any BD syringes. Over our more than 125-year history, we have served the health care system’s need for essential high quality medical products, including manufacturing 2 billion additional syringes and needles to support the global pandemic response to COVID-19.”

Syringe manufacturers in China cited

In late November 2023, the FDA announced its probe into reports of leaks, breakages and other quality problems with plastic syringes manufactured in China “that are used for injecting fluids into or withdrawing fluids from, the body,” according to the health regulator.

On March 14, the FDA issued an update on warning letters sent to three entities: Jiangsu Shenli Medical Production Co. Ltd, Medline Industries, LP and Sol-Millennium Medical Inc., describing violations related to the “sale and distribution of unauthorized plastic syringes that had not been cleared or approved by the FDA,” according to a new release.

“In addition, we are actively evaluating quality issues and performance testing failures with plastic syringes made by Jiangsu Caina Medical Co Ltd., a China-based manufacturer sited in the warning letter issued to Medline Industries, LP. The FDA will take additional steps as appropriate,” the FDA stated.

In its August 16 update, the FDA continued to recommend that healthcare providers “use syringes not manufactured in China, if possible.

“At this time, glass syringes, pre-filled syringes or syringes used for topical purposes are not included. If you only have syringes manufactured in China, then continue to use them as needed until you are able to use alternative syringes and closely monitor for leaks, breakage and other problems,” the FDA announced.

In March, BD was named to Fortune’s 2024 list of America’s Most Innovative Companies, and in September, the company announced that it had been named to TIME’s 2024 list of the World’s Best Companies based on employee feedback.

BD’s operations in North Canaan have also been recognized by the U.S. Environmental Protection Agency for achieving the Energy Star Challenge for Industry for energy reduction. The site is a landfill-free site where waste is reduced, recycled or converted into energy.

Latest News

Residents tear down Patriot Front signs in North Canaan and Falls Village

A Patriot Front sign hangs in front of the Canfield Building on Main Street in North Canaan on Wednesday, Nov. 11. The sign was removed later that day.

Madi Long

NORTH CANAAN — Residents in North Canaan and Falls Village have taken down signs bearing the name Patriot Front, which the Southern Poverty Law Center classifies as a white nationalist hate group. Connecticut State Police said they referred two incidents to hate crimes investigators.

On Nov. 2, a Troop B sergeant spotted a sign on a utility pole near Route 7 and North Elm Street. State police contacted the utility company, which took down the sign.

Keep ReadingShow less

Sharon revisits speed cameras, weighs humps

Sharon revisits speed cameras, weighs humps
A speed camera in Washington, Conn. Sharon selectmen have discussed installing similar cameras.
Alec Linden

SHARON — A group of more than 20 residents who live along Jewett Hill Road has petitioned the town to install speed humps on their roadway. Jewett Hill Road runs less than a mile between Calkinstown Road and Jackson Hill Road.

The petition prompted a broader discussion about speeding at the Sharon Board of Selectmen meeting on Nov. 10. First Selectman Casey Flanagan said he plans to revive an earlier proposal to use speed cameras on town roads and resume talks with an installation company.

Keep ReadingShow less
North Canaan recovers $15,000 in nip fees sent to New Canaan
North Canaan Town Hall
File photo

NORTH CANAAN — The town has recovered $15,000 in lost revenue from a surcharge on miniature liquor bottles after Treasurer Melanie Neely discovered that the money had mistakenly been sent to New Canaan.

First Selectman Jesse Bunce announced the recovery at the Nov. 9 Board of Selectmen meeting, drawing a round of applause. Bunce investigated the discrepancy after Neely brought it to his attention.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

Northwest Corner veterans help one another get care

Couch-Pipa VFW Post 6851

Patrick Stachniak

NORTH CANAAN — As the flags from Veterans Day parades are furled and the public tributes fade, veterans in Connecticut’s rural Northwest Corner still face the quieter work of finding care and talking about the pain and anguish they brought home.

Those challenges can become more acute as winter and the holidays approach, said Keith Appleton, an Army veteran and licensed master social worker at Mountainside Treatment Center.

Keep ReadingShow less
Northwest Corner honors veterans at schools and memorials

Local veterans salute during the Veterans Day ceremony in Kent.

Ruth Epstein

NORTHWEST CORNER — Students, veterans and neighbors across the Northwest Corner marked Veterans Day with school assemblies and ceremonies at town memorials.

Salisbury Central School held its assembly Tuesday, Nov. 10. Schools in Falls Village, Cornwall, Sharon and Kent also observed the holiday.

Keep ReadingShow less
Salisbury’s median home sale price rises 5% to $920,000

This four-bedroom house at 175 Main St. in Salisbury sold for $990,000 on Sept. 30. It sold for $1,025,000 in January 2022.

Christine Bates

SALISBURY — The median sale price of a single-family home in Salisbury rose to $920,000 for the 12 months ended Oct. 31, up 5.1% from $875,000 a year earlier and 6.4% from $865,000 for the same period in 2024. The figures exclude condominiums.

The rolling 12-month median peaked at $1.35 million in May 2025 and fell to $775,000 at the start of 2026. It has remained above $900,000 since July.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.